Nearly 100 people at this NJ school got brain tumors — a survivor demands answers

A cancer survivor is vowing to untangle the twisted mystery of why almost 100 people associated with a New Jersey high school have developed “extremely” rare malignant brain tumors.

Al Lupiano is among the 94 former staff and students from Colonia High School in the Woodbridge Township School District who have been stricken by the devastating diagnoses in recent years.

“I will not rest until I have answers,” Lupiano, 50, declared in an interview with NJ.com and the Star-Ledger on Thursday. “I will uncover the truth.”

Among the others diagnosed with brain cancer was Lupiano’s younger sister, who passed away from the disease in February at the age of 44.

The devoted brother promised his sister on her deathbed that he would get to the bottom of what was causing the apparent cancer cluster at Colonia High. On Tuesday — after a public push by Lupiano — local officials approved an emergency probe of the school.

Keep reading

Researchers Discover Cannabis-Mushroom Combination that ‘Kills Over 90% of Colon Cancer Cells’

For years, when it comes to cannabis research, Israeli scientists have been pioneers. Thanks to the tyrannical schedule one rating in the United States, Israel is years ahead of American research, and the latest information out of Herzliya, Israel, is proof.

Though breast cancer is more diagnosed in the United States, colorectal cancer kills far more people, coming in as the second most deadly cancer in the world, just under lung cancer. For the last several years, scientists with Cannabotech, a biomedical company developing oncological products using cannabis, have been developing an “Integrative-Colon” product they say kills over 90% of colon cancer cells. 

According to Cannabotech, the have concluded a study using not only cannabis, but a unique combination of cannabinoids and mushroom extracts, which they tested on various colon cancer subtypes, representing different molecular changes common in these colon cancer subtypes. Their results of the cell model study were astounding, showing that its “Integrative-Colon” products killed over 90% of colon cancer cells — and they attribute this to to the mushroom and cannabis combination.

Results showed that Cannabotech’s Integrative-Colon products composition is significantly more effective than each cannabinoid individually, and there is a strong synergy between the active ingredients. These results reinforce Cannabotech’s claim that to achieve effective treatment in the oncology field, it is necessary to build a defined, accurate and science-based formula, which cannot be obtained in any cannabis strain that exists in nature.

Given the fact that the survival rate for colorectal cancer is just 65%, the idea that an easily grown plant and fungus could be used to save hundreds of thousands of lives, is inspiring to say the least.

Keep reading

Ivermectin found to suppresses tumour development

Researchers in Japan and the United States have found that ivermectin, a drug used to kill parasites, suppresses tumour development in epithelial ovarian cancer.

Ivermectin exerts an anti-tumour effect on epithelial ovarian cancer (EOC) cells by interacting with the new gene target KPNB1. Because ivermectin is already approved to treat parasitic infections in patients, experiments for its effectiveness in an anti-cancer regimen is expected to significantly lower costs compared to untested drug compounds.

“EOC is a challenging disease to treat because of its heterogeneity. The mortality rate has stayed steady for decades. We need new drugs and also new drug targets,” said Osaka University Gynecologist Michiko Kodama.

Keep reading